Neoadjuvant Radiation Therapy Should Still Be Considered in Select Patients With Borderline Resectable Pancreas Cancer

Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):709. doi: 10.1016/j.ijrobp.2023.02.051.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Neoadjuvant Therapy*
  • Pancreatic Neoplasms* / drug therapy
  • Pancreatic Neoplasms* / radiotherapy
  • Pancreatic Neoplasms* / surgery